EFFECT OF SUSTAINED-RELEASE NICARDIPINE, CHLORTHALIDONE, AND THE 2 DRUGS COMBINED IN PATIENTS WITH MILD TO MODERATE HYPERTENSION

被引：0
|
作者：
STORNELLO, M
VALVO, EV
SCAPELLATO, L
机构：
来源：
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 1990年 / 47卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：405 / 411
页数：7
相关论文
共 50 条
  • [41] Central nervous system effects of moxonidine sustained release formulation in patients with mild to moderate essential hypertension.
    Kemme, MJB
    Van der Post, J
    Schoemaker, R
    van Gerven, JM
    Cohen, AF
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P72 - P72
  • [42] Central nervous system effects of moxonidine experimental sustained release formulation in patients with mild to moderate essential hypertension
    Kemme, MJB
    Post, JPV
    Schoemaker, RC
    Straub, M
    Cohen, AF
    van Gerven, JMA
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 55 (06) : 518 - 525
  • [43] THE RELATIONSHIP OF DOSE TO THE ANTIHYPERTENSIVE RESPONSE OF VERAPAMIL-SUSTAINED RELEASE IN PATIENTS WITH MILD TO MODERATE ESSENTIAL-HYPERTENSION
    MCMAHON, FG
    REDER, RF
    JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 29 (11): : 1003 - 1007
  • [44] Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain
    van Seventer, R
    Smit, JM
    Schipper, RM
    Wicks, MA
    Zuurmond, WWA
    CURRENT MEDICAL RESEARCH AND OPINION, 2003, 19 (06) : 457 - 469
  • [45] EFFECT OF COMBINATION THERAPY WITH AROTINOLOL AND SUSTAINED-RELEASE NIFEDIPINE IN PATIENTS WITH ESSENTIAL-HYPERTENSION RESISTANT TO MONOTHERAPY
    TAKEDA, K
    NAKATA, T
    UCHIDA, A
    FUJITA, H
    NAKAMURA, K
    TAKESAKO, T
    ITOH, H
    SASAKI, S
    NAKAGAWA, M
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1994, 55 (07): : 817 - 827
  • [46] Effect of sustained-release diltiazem on ambulatory blood pressure and left ventricular mass in elderly patients with hypertension
    Fogari, R
    Zoppi, A
    Mugellini, A
    Preti, P
    Corradi, L
    Lusardi, P
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1998, 59 (10): : 725 - 736
  • [47] COMPARISON OF THE EFFICACY AND TOLERABILITY OF LISINOPRIL AND SUSTAINED-RELEASE VERAPAMIL IN OLDER PATIENTS WITH HYPERTENSION
    WEIR, MR
    LAVIN, PT
    CLINICAL THERAPEUTICS, 1991, 13 (03) : 401 - 408
  • [48] COMPARISON OF THE EFFICACY AND TOLERABILITY OF LISINOPRIL AND SUSTAINED-RELEASE VERAPAMIL IN BLACK PATIENTS WITH HYPERTENSION
    WEIR, MR
    KONG, BW
    JENKINS, P
    LAVIN, PT
    CLINICAL THERAPEUTICS, 1991, 13 (03) : 409 - 416
  • [49] COMPARISON OF THE BRONCHODILATING EFFECT OF 2 DOSES OF A SUSTAINED-RELEASE THEOPHYLLINE
    PRIGNOT, J
    DELAUNOIS, L
    LULLING, J
    DELWICHE, JP
    VANDENPLAS, F
    RESPIRATION, 1984, 46 (02) : 166 - 173
  • [50] TREATMENT OF MILD HYPERTENSION WITH LOW ONCE-DAILY DOSES OF A SUSTAINED-RELEASE CAPSULE FORMULATION OF VERAPAMIL
    DAVIS, PJ
    FAGAN, TC
    TOPMILLER, MJ
    LEVINE, JH
    FERDINAND, KC
    JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 35 (01): : 52 - 58
12345